CARACAS, Aug 25 (Reuters) - Drug maker Pfizer's Venezuelan unit paid 36.59 million bolivars ($17 million) in back taxes after auditors questioned its transfer pricing methodology, Venezuela's tax service said in a statement on Tuesday. The Andean nation's tax service submitted the claim for back taxes in May after an audit of Pfizer's (PFE.N) tax returns. The claim cited omissions of operational revenue and the way Pfizer accounted for sales to distributors and export clients in its report.
Entradas
No hay comentarios:
Publicar un comentario